This is a public procurement opportunity for a 48-month supply of probes and reagents for fluorescence in situ hybridization (FISH) for the Pathological Anatomy Department at the IRCCS Giovanni Paolo II Cancer Institute in Bari, Italy. The contract is being awarded through an open European tender pr
Contract awarded. Originally published 1 years ago.
Only 2 prior awards here — too little to read.
In healthcare medical, IRCCS INSTITUTE OF TUMORS GIOVANNI PAOLO II has awarded 2 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the supply of multi-dose bags and the simultaneous establishment of a sterile laboratory (UFA) for the preparation and handling of chemotherapy active ingredients. The contract is for a duration of 60 months and includes all necessary equipment for the operation of the laborat
This is a public procurement opportunity for the purchase of one advanced robotic system for various surgical specialties, including Urology, General Surgery, Gynecology, Otorhinolaryngology, and Thoracic Surgery. The contract includes the supply of consumables for a period of thirty-six months, as
This is a public procurement opportunity for the acquisition of four ergonomic workstations designed for pathology, aimed at reducing operator samples. The contract includes full risk assistance and specialized support for the entire warranty period of 24 months. The procurement is conducted through
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
